Novavax, a U.S. biotech company, secured a licensing agreement with Sanofi worth up to $1.2 billion for COVID-19 vaccines, dispelling concerns about its financial stability. As part of the deal, Sanofi will acquire a 4.9% stake in Novavax for $70 million, doubling the biotech company’s market value to about $1.4 billion. This marks a significant increase from its market capitalization of $628 million just a day before the agreement, although it remains lower than its peak of $20 billion in 2021.
The licensing agreement with Sanofi includes an upfront cash payment of $500 million, milestone-based payments, and proceeds from the equity stake sale. This financial boost is expected to improve Novavax’s balance sheet, which has been hindered by challenges in getting its COVID-19 vaccine to market promptly, resulting in a decline of over 98% in stock value since its peak. Sanofi will be able to co-commercialize Novavax’s COVID-19 vaccine in most countries and combine it with its own flu vaccines to create a flu and COVID-19 shot.
The agreement is seen as an opportunity for Sanofi to strengthen its flu vaccine franchise as competitors like Pfizer and Moderna develop similar products. Novavax has withdrawn a “going concern” notice put in place in February 2021 following issues with manufacturing and regulatory delays related to its COVID-19 vaccine. The company also revised its 2024 sales forecast, excluding contributions from the Sanofi deal, to between $400 million and $600 million.
In the first quarter of 2022, Novavax reported a net loss of $148 million, down from $294 million in the same period a year ago. Analysts anticipate that the licensing agreement with Sanofi will pave the way for a potential combination flu and COVID-19 vaccine in the future.
Marvin Harrison Jr. made headlines recently for not attending the NFLPA Rookie Premiere and being…
Over the weekend, Donald Trump mentioned the possibility of serving three terms as president during…
A recent population-based cohort study of Swedish data found that women with adverse pregnancy outcomes…
Asus has recently launched a new OLED gaming monitor with a unique feature that the…
Micron Technology saw its shares rise by 4% in the morning session on Monday following…
Tokio Marine Holdings’ international business has reported a significant increase in profits for 2023, totaling…